Muscular dystrophy and neuronal migration disorder caused by mutations in a glycosyltransferase, POMGnT1

被引:532
作者
Yoshida, A
Kobayashi, K
Manya, H
Taniguchi, K
Kano, H
Mizuno, M
Inazu, T
Mitsuhashi, H
Takahashi, S
Takeuchi, M
Herrmann, R
Straub, V
Talim, B
Voit, T
Tapaloglu, H
Toda, T
Endo, T
机构
[1] Osaka Univ, Grad Sch Med, Div Funct Genom, Dept Postgenom & Dis, Suita, Osaka 5650871, Japan
[2] Kirin Brewery Co Ltd, Cent Labs Key Technol, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan
[3] Tokyo Metropolitan Inst Gerontol, Dept Glycobiol, Itabashi Ku, Tokyo 1730015, Japan
[4] Noguchi Inst, Res Dept, Itabashi Ku, Tokyo 1730003, Japan
[5] Univ Essen Gesamthsch, Dept Pediat & Pediat Neurol, D-45122 Essen, Germany
[6] Hacettepe Childrens Hosp Med Ctr, Dept Pediat Pathol, TR-06100 Ankara, Turkey
[7] Hacettepe Childrens Hosp Med Ctr, Dept Pediat Neurol, TR-06100 Ankara, Turkey
关键词
D O I
10.1016/S1534-5807(01)00070-3
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Muscle-eye-brain disease (MEB) is an autosomal recessive disorder characterized by congenital muscular dystrophy, ocular abnormalities, and lissencephaly. Mammalian O-mannosyl glycosylation is a rare type of protein modification that is observed in a limited number of glycoproteins of brain, nerve, and skeletal muscle. Here we isolated a human cDNA for protein O-mannose beta-1,2-N-acetylglucosaminyltransferase (POMGnT1) which participates in O-mannosyl glycan synthesis. We also identified six independent mutations of the POMGnT1 gene in six patients with MEB. Expression of most frequent mutation revealed a great loss of the enzymatic activity. These findings suggest that interference in O-mannosyl glycosylation is a new pathomechanism for muscular dystrophy as well as neuronal migration disorder.
引用
收藏
页码:717 / 724
页数:8
相关论文
共 27 条
[1]   The fukutin protein family - predicted enzymes modifying cell-surface molecules [J].
Aravind, L ;
Koonin, EV .
CURRENT BIOLOGY, 1999, 9 (22) :R836-R837
[2]   Muscle membrane-skeleton protein changes and histopathological characterization of muscle-eye-brain disease [J].
Auranen, M ;
Rapola, J ;
Pihko, H ;
Haltia, M ;
Leivo, I ;
Soinila, S ;
Virtanen, I ;
Kalimo, H ;
Anderson, LVB ;
Santavuori, P ;
Somer, H .
NEUROMUSCULAR DISORDERS, 2000, 10 (01) :16-23
[3]  
Brown SC, 1999, J CELL SCI, V112, P209
[4]   3 MUSCULAR-DYSTROPHIES - LOSS OF CYTOSKELETON EXTRACELLULAR-MATRIX LINKAGE [J].
CAMPBELL, KP .
CELL, 1995, 80 (05) :675-679
[5]   Expression of three Caenorhabditis elegans N-acetylglucosaminyltransferase I genes during development [J].
Chen, SH ;
Zhou, SH ;
Sarkar, M ;
Spence, AM ;
Schachter, H .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (01) :288-297
[6]  
Chiba A, 1997, J BIOL CHEM, V272, P2156
[7]   Assignment of the muscle-eye-brain disease gene to 1p32-p34 by linkage analysis and homozygosity mapping [J].
Corman, B ;
Avela, K ;
Pihko, H ;
Santavuori, P ;
Talim, B ;
Topaloglu, H ;
de la Chapelle, A ;
Lehesjoki, AE .
AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 64 (01) :126-135
[8]   Glycoprotein glycosylation and cancer progression [J].
Dennis, JW ;
Granovsky, M ;
Warren, CE .
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 1999, 1473 (01) :21-34
[9]   DIAGNOSTIC-CRITERIA FOR WALKER-WARBURG SYNDROME [J].
DOBYNS, WB ;
PAGON, RA ;
ARMSTRONG, D ;
CURRY, CJR ;
GREENBERG, F ;
GRIX, A ;
HOLMES, LB ;
LAXOVA, R ;
MICHELS, VV ;
ROBINOW, M ;
ZIMMERMAN, RL .
AMERICAN JOURNAL OF MEDICAL GENETICS, 1989, 32 (02) :195-210
[10]  
Dubowitz V, 1999, Neuromuscul Disord, V9, P446